• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌的保守治疗

Conservative management of breast cancer.

作者信息

Sarrazin D, Dewar J A, Arriagada R, Benhamou S, Benhamou E, Lasser P, Fontaine F, Travagli J P, Spielmann M, Le Chevalier T

出版信息

Br J Surg. 1986 Aug;73(8):604-6. doi: 10.1002/bjs.1800730804.

DOI:10.1002/bjs.1800730804
PMID:3742167
Abstract

Between 1970 and 1982, 592 patients with T1 and small T2 breast cancers were treated at the Institut Gustave-Roussy by a combination of conservative surgery and radiotherapy. Mean follow-up was 78 months. The actuarial survival rate at 5 and 10 years was 92 per cent and 80 per cent respectively. There were 36 locoregional relapses of which 26 were within the treated breast. The actuarial relapse rate within the breast was 5 per cent at 5 years. If operable, a relapse within the breast did not significantly affect overall survival. The efficacy of conservative management of small breast tumours is confirmed.

摘要

1970年至1982年间,古斯塔夫 - 鲁西研究所对592例T1期和小T2期乳腺癌患者采用了保守手术和放疗相结合的治疗方法。平均随访时间为78个月。5年和10年的精算生存率分别为92%和80%。有36例局部区域复发,其中26例发生在接受治疗的乳房内。乳房内的精算复发率在5年时为5%。如果可以手术,乳房内的复发对总生存率没有显著影响。小乳腺肿瘤保守治疗的疗效得到了证实。

相似文献

1
Conservative management of breast cancer.乳腺癌的保守治疗
Br J Surg. 1986 Aug;73(8):604-6. doi: 10.1002/bjs.1800730804.
2
Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy.古斯塔夫-鲁西研究所的经验:对接受切除和放疗的早期乳腺癌患者局部区域复发情况的分析
Int J Radiat Oncol Biol Phys. 1985 Jan;11(1):137-45. doi: 10.1016/0360-3016(85)90372-4.
3
Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institut Gustave-Roussy.保乳治疗乳腺癌时腋窝的处理:古斯塔夫 - 鲁西研究所治疗的592例患者
Int J Radiat Oncol Biol Phys. 1987 Apr;13(4):475-81. doi: 10.1016/0360-3016(87)90060-5.
4
[Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].[40岁及以下年轻女性乳腺癌乳房切除或保乳手术后的局部复发:15年结果]
Magy Onkol. 2005;49(3):203, 205-8. Epub 2005 Oct 25.
5
Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). IGR Breast Cancer Group.采用保乳手术和放疗治疗的乳腺癌患者的局部复发率和对侧肿瘤发生率(古斯塔夫·鲁西研究所,1970 - 1982年)。IGR乳腺癌研究小组。
Cancer. 1995 Dec 1;76(11):2260-5. doi: 10.1002/1097-0142(19951201)76:11<2260::aid-cncr2820761113>3.0.co;2-d.
6
Cosmetic results following lumpectomy, axillary dissection and radiotherapy for small breast cancers.
Radiother Oncol. 1988 Aug;12(4):273-80. doi: 10.1016/0167-8140(88)90016-3.
7
[Conservative treatment of cancer of the breast. Apropos of 108 cases].[乳腺癌的保守治疗。关于108例病例]
J Chir (Paris). 1985 Jan;122(1):37-41.
8
Breast conservation in the treatment of early breast cancer. A 20-year follow-up.
Cancer. 1984 Jan 15;53(2):349-55. doi: 10.1002/1097-0142(19840115)53:2<349::aid-cncr2820530230>3.0.co;2-b.
9
Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience.局限性浸润性乳腺癌保乳手术的结果:962例受试患者的分析:24年经验
J Surg Oncol. 2000 Jun;74(2):108-15. doi: 10.1002/1096-9098(200006)74:2<108::AID-JSO6>3.0.CO;2-Y.
10
Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.可手术乳腺癌保守治疗中的腋窝处理:清扫术还是放射治疗?一项长达15年随访的随机研究结果
J Clin Oncol. 2004 Jan 1;22(1):97-101. doi: 10.1200/JCO.2004.12.108.

引用本文的文献

1
Novel techniques for intraoperative assessment of margin involvement.术中评估切缘受累情况的新技术。
Ecancermedicalscience. 2018 Jan 10;12:795. doi: 10.3332/ecancer.2018.795. eCollection 2018.
2
Oncologic safety of conservative mastectomy in the therapeutic setting.治疗性保乳手术的肿瘤学安全性。
Gland Surg. 2016 Feb;5(1):37-46. doi: 10.3978/j.issn.2227-684X.2015.05.13.
3
Psychosocial sequelae of breast cancer and its treatment.乳腺癌及其治疗的心理社会后遗症。
Ann Behav Med. 1996 Jun;18(2):110-25. doi: 10.1007/BF02909583.
4
Involvement in decision-making about treatment and ovarian cancer survivor quality of life.参与治疗决策与卵巢癌幸存者生活质量
Gynecol Oncol. 2012 Mar;124(3):465-70. doi: 10.1016/j.ygyno.2011.10.029. Epub 2011 Oct 29.
5
Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression.家族性早期乳腺癌且 EZH2 高表达患者远处转移风险增加。
Breast Cancer Res Treat. 2012 Apr;132(2):429-37. doi: 10.1007/s10549-011-1591-2. Epub 2011 May 26.
6
[Is axillary dissection in clinically lymph node-negative breast carcinoma further indicated?].[临床淋巴结阴性乳腺癌是否需要进一步行腋窝清扫?]
Strahlenther Onkol. 1998 Dec;174(12):605-12. doi: 10.1007/BF03038507.
7
Survival following locoregional recurrence after breast conservation therapy for cancer.乳腺癌保乳治疗后局部区域复发后的生存情况。
Ann Surg. 1990 Aug;212(2):166-72. doi: 10.1097/00000658-199008000-00009.
8
Non-tumour morbidity and mortality after modified radical mastectomy.改良根治性乳房切除术后的非肿瘤性发病率和死亡率。
Ann R Coll Surg Engl. 1992 Sep;74(5):314-7.